Clinical outcomes of beta-bactam monotherapy versus beta-lactam plus azithromycin in hospitalized patients with community-acquired pneumoniae
Journal of Antimicrobial Chemotherapy · 2026
DOI: 10.1093/jac/dkag158 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2026. Verfasst von Ilona Zhygalova Zhygalova und 8 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases Unit, Internal Medicine Department, Complexo Hospitalario Universitario de Vigo, Vigo, Pontevedra 36312, Spain. Hauptthemen laut MEDLINE: Azithromycin, Community-Acquired Pneumonia, Anti-Bacterial Agents, beta-Lactams. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Abstract (Originalsprache)
Background
We aim to assess the clinical efficacy of β-lactam plus azithromycin compared with β-lactam monotherapy in the empirical treatment of community-acquired pneumonia (CAP).
Methods
We conducted a retrospective matched cohort study in the Vigo Health Area (Spain), including adults discharged in 2023 with a primary diagnosis of CAP. Participants were classified according to the empirical therapy received and matched by severity. Exclusion criteria were immunocompromised status, alternative empirical regimens or initial admission to intensive care unit. Clinical efficacy was defined as the absence of oxygen requirement, fever and ≥50% reduction in C-reactive protein and/or procalcitonin at 72–96 h after treatment initiation.
Results
A total of 246 patients were included (121 receiving monotherapy and 125 receiving combination therapy). Although the SOFA score did not differ between groups, overall severity scores were higher in the monotherapy group. Clinical efficacy was similar between treatment groups (65% versus 62%, P = 0.597). In the multivariable analysis of the overall cohort, SOFA ≥2 was the only variable independently associated with reduced clinical efficacy [odds ratio 0.5, 95% confidence interval (0.33–0.93), P = 0.026], whereas treatment strategy was not significantly associated with clinical efficacy.
Conclusions
The addition of azithromycin to β-lactam was not associated with improved clinical efficacy, either overall or in the subgroup with SOFA ≥2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Infectious Diseases Unit, Internal Medicine Department, Complexo Hospitalario Universitario de Vigo, Vigo, Pontevedra 36312, Spain.
- Galicia Sur Health Research Institute, Vigo, Pontevedra 36312, Spain.
- Microbiology Department, Complexo Hospitalario Universitario de Vigo, Vigo, Pontevedra 36312, Spain.
- Pharmacy Department, Complexo Hospitalario Universitario de Vigo, Vigo, Pontevedra 36312, Spain.
ORCID-Profile: Ilona Zhygalova Zhygalova
Zitieren
APA
Zhygalova Zhygalova, I., Blanco López, I., Dopazo Sotillo, S., Carreira Sampayo, U., Rubiñán Iglesias, P., Sousa, A., Cabrera Alvargonzález, J. J., Pérez-Landeiro, A., & Pérez-Rodríguez, M. T. (2026). Clinical outcomes of beta-bactam monotherapy versus beta-lactam plus azithromycin in hospitalized patients with community-acquired pneumoniae. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkag158
Vancouver
Zhygalova Zhygalova I, Blanco López I, Dopazo Sotillo S, Carreira Sampayo U, Rubiñán Iglesias P, Sousa A, et al. Clinical outcomes of beta-bactam monotherapy versus beta-lactam plus azithromycin in hospitalized patients with community-acquired pneumoniae. Journal of Antimicrobial Chemotherapy. 2026. doi:10.1093/jac/dkag158
BibTeX
@article{ZhygalovaZhygalova2026,
author = {Zhygalova Zhygalova, Ilona and Blanco López, Iago and Dopazo Sotillo, Silvia and Carreira Sampayo, Uxía and Rubiñán Iglesias, Pablo and Sousa, Adrián and Cabrera Alvargonzález, Jorge Julio and Pérez-Landeiro, Antonio and Pérez-Rodríguez, María Teresa},
title = {Clinical outcomes of beta-bactam monotherapy versus beta-lactam plus azithromycin in hospitalized patients with community-acquired pneumoniae},
journal = {Journal of Antimicrobial Chemotherapy},
year = {2026},
doi = {10.1093/jac/dkag158}
}
EUVIMED